Executive Vice President, Head of Clinical & Pharmaceutical Development
Tamara Vukmirovic was appointed as Executive Vice President, Head of Clinical & Pharmaceutical Development, and joined the Executive Committee in September 2025, with responsibility for Global Project and Portfolio Management, Global Clinical Delivery, Global Biometrics, Global Pharmaceutical Development / CMC, Early Sciences, Clinical Quality Assurance, and Global Life Cycle Management. In addition, she remains a Board Member of Ferring’s subsidiary Syntese A/S, a position she has held since April 2022.
Tamara joined Ferring in 2005 as Global Regulatory Associate, and held positions of increasing seniority within this function. She headed teams covering a number of therapeutic areas, and in 2018 was appointed Vice-President, CMC Global Regulatory Affairs. She held this post until 2023 when she transferred into Technical Operations. In May 2024 she became Head of the Supply Excellence Office and acting Chief of Staff for TechOps, before being promoted to her present role.
Tamara holds an M.Sc. in Pharmacy from the Danish University of Pharmaceutical Sciences, and an International Medical Diploma in Strategy and Innovation from Copenhagen Business School.
